Trial
NCT03358407
GSK2983559 First Time in Human Study
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Inflammatory Bowel Diseases
Intervention
GSK2983559
Why stopped
Terminated due to non clinical toxicology findings and reduced safety margins.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-27